FM

Frazier Management Portfolio holdings

AUM $1.12M
This Quarter Return
-25.8%
1 Year Return
+150.24%
3 Year Return
+430.4%
5 Year Return
+1,926.83%
10 Year Return
AUM
$388M
AUM Growth
+$388M
Cap. Flow
+$15.9M
Cap. Flow %
4.11%
Top 10 Hldgs %
90.41%
Holding
17
New
1
Increased
1
Reduced
2
Closed
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ANAB icon
1
AnaptysBio
ANAB
$569M
$148M 38.13% 2,316,447
APTX
2
DELISTED
Aptinyx Inc. Common Stock
APTX
$52.8M 13.61% 3,190,079
COLL icon
3
Collegium Pharmaceutical
COLL
$1.22B
$32.4M 8.36% 1,887,332
GRTS
4
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$31.9M 8.22% 2,061,758 -4 -0% -$62
IOVA icon
5
Iovance Biotherapeutics
IOVA
$807M
$19.4M 5% 2,188,331
KRYS icon
6
Krystal Biotech
KRYS
$4.27B
$18.2M 4.69% 875,000 +250,000 +40% +$5.2M
ALNA
7
DELISTED
Allena Pharmaceuticals, Inc. Common Stock
ALNA
$18.2M 4.68% 3,330,373
TPST icon
8
Tempest Therapeutics
TPST
$44M
$11.1M 2.86% +1,396,615 New +$11.1M
SRRA
9
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$10.7M 2.76% 8,112,121
ALPN
10
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$8.09M 2.09% 2,199,011
ITRM icon
11
Iterum Therapeutics
ITRM
$30.2M
$7.71M 1.99% 1,538,316
SYBX icon
12
Synlogic
SYBX
$17M
$6.07M 1.57% 865,407
KZR icon
13
Kezar Life Sciences
KZR
$28.9M
$5.9M 1.52% 250,000
NBRV
14
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$5.86M 1.51% 4,012,374 -244,152 -6% -$356K
ETTX
15
DELISTED
Entasis Therapeutics Holdings Inc.
ETTX
$5.49M 1.42% 1,349,953
CDTX icon
16
Cidara Therapeutics
CDTX
$1.66B
$3.08M 0.8% 1,312,258
BLCM
17
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$3.07M 0.79% 1,051,441